Sivik Global Healthcare’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-8,224
Closed -$3.79M – 50
2021
Q2
$3.79M Buy
+8,224
New +$3.31M 0.74% 36
2020
Q3
– Sell
-10,280
Closed -$3.7M – 52
2020
Q2
$3.7M Buy
+10,280
New +$3.31M 1.23% 39
2020
Q1
– Sell
-10,280
Closed -$3.32M – 50
2019
Q4
$3.32M Buy
+10,280
New +$3.12M 1.23% 39
2019
Q3
– Sell
-5,140
Closed -$1.84M – 51
2019
Q2
$1.84M Sell
5,140
-7,710
-60% -$2.43M 0.45% 57
2019
Q1
$3.88M Sell
12,850
-2,570
-17% -$749K 1.43% 33
2018
Q4
$4.5M Hold
15,420
– – 2.43% 19
2018
Q3
$5.51M Hold
15,420
– – 1.97% 22
2018
Q2
$4.19M Sell
15,420
-5,140
-25% -$1.31M 1.61% 30
2018
Q1
$4.73M Buy
20,560
+5,140
+33% +$1.18M 2.21% 17
2017
Q4
$3.28M Hold
15,420
– – 1.22% 39
2017
Q3
$2.99M Buy
15,420
+5,140
+50% +$957K 1.02% 37
2017
Q2
$1.74M Hold
10,280
– – 0.64% 55
2017
Q1
$1.71M Buy
+10,280
New +$1.62M 0.79% 45
2016
Q4
– Sell
-15,420
Closed -$2.73M – 60
2016
Q3
$2.73M Buy
+15,420
New +$2.47M 1.37% 33
2016
Q2
– Sell
-10,280
Closed -$1.62M – 60
2016
Q1
$1.62M Buy
10,280
+5,140
+100% +$786K 0.72% 51
2015
Q4
$960K Sell
5,140
-5,140
-50% -$830K 0.46% 57
2015
Q3
$1.76M Sell
10,280
-5,140
-33% -$1.04M 0.85% 49
2015
Q2
$3.27M Buy
15,420
+206
+1% +$40.2K 1.14% 34
2015
Q1
$2.75M Hold
15,214
– – 0.93% 48
2014
Q4
$2.73M Buy
15,214
+5,962
+64% +$1.05M 1.11% 45
2014
Q3
$1.48M Hold
9,252
– – 0.67% 55
2014
Q2
$1.61M Sell
9,252
-1,028
-10% -$153K 0.81% 51
2014
Q1
$1.49M Buy
+10,280
New +$1.51M 0.93% 49

Other funds holding ILMN

Sivik Global Healthcare's ILMN Position: Q3 2021 in Review

Sivik Global Healthcare sold out of Illumina (ILMN) in Q3 2021, closing a stake of 8,224 shares — an estimated $3.79M sold.

Sivik Global Healthcare first reported a position in ILMN in Q1 2014 and held it in 23 quarters. The position peaked at $5.51M in Q3 2018. 1,073 funds tracked by Wall St. Rank hold ILMN as of Q3 2021.

  • Sivik Global Healthcare reported no remaining Illumina position as of Q3 2021 after selling out during the quarter.
  • Sivik Global Healthcare sold 8,224 Illumina shares in Q3 2021, an estimated $3.79M.
  • Sivik Global Healthcare first reported a position in Illumina in Q1 2014 and held it in 23 quarters.
  • Sivik Global Healthcare's Illumina position peaked at $5.51M in Q3 2018.
  • 1,073 funds tracked by Wall St. Rank held Illumina as of Q3 2021.

Based on Sivik Global Healthcare's 13F filing for Q3 2021, filed 12 Nov 2021.